ANITRAZAFEN
UNII 2Y065P7MYR

Substance Identification & Data

This profile provides standardized clinical and technical data for Anitrazafen, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2Y065P7MYR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 63119-27-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2Y065P7MYR

CAS Registry Number

63119-27-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ANITRAZAFEN

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H17N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HDNJXZZJFPCFHG-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C81668

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44410

Unique identification number in the NCBI database of chemical substances.

INN ID

4748

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1(nnc(nc1-c2ccc(cc2)OC)C)-c3ccc(cc3)OC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Anitrazafen. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.